Talk One- Occult Axillary Breast Cancer
Presenter: Nara L. Tashjian, MD, MBA

Talk Two- Update on Neoadjuvant Immunotherapy for Early Breast Cancer
Presenter: Tina J. Hieken, MD, FACS

LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to: 

1.    Describe current trends and management of occult axillary breast cancer
2.    Evaluate overall survival of patients with occult axillary breast cancer in comparison to node positive primary breast cancer
3.    Identify prognostic factors that affect overall survival in patients with occult axillary breast cancer

4.    Recognize the expanding role of immunotherapy prior to surgery in patients with operable breast cancer
5.    Describe perioperative considerations following neoadjuvant immunotherapy

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

To claim credit for livestream participation in this course, learners must view the content during the hours posted for the live activity.  This course is not approved for on-demand delivery. 

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.